Withus Pharmaceutical Co Ltd
KOSDAQ:330350
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of Withus Pharmaceutical Co Ltd (330350) under the Base Case is 5 607.04 KRW per share. Compared with the current market price of 6 700 KRW, the stock appears Overvalued by 16% .
The intrinsic value is calculated using the DCF method. The model assumes revenue grows about 21% a year over the next five years, below its five-year pace of 32%. Net margin ends at 6% by 2033, below its five-year average of 6.1%.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Withus Pharmaceutical Does
Withus Pharmaceutical is a South Korean drug company that develops, manufactures, and sells medicines. Its products are sold through the healthcare supply chain, mainly to hospitals, clinics, pharmacies, and distributors that buy medicines for patients and consumers.
- Headquarters
- Korea KR
- Employees
- 217
- IPO date
- Jul 3, 2020
Earnings Waterfall
Withus Pharmaceutical Co Ltd
What is the Intrinsic Value of one Withus Pharmaceutical Co Ltd stock?
The intrinsic value for Withus Pharmaceutical Co Ltd (330350) under the Base Case is 5 607.04 KRW.
Is Withus Pharmaceutical Co Ltd stock undervalued or overvalued?
Compared with the current market price of 6 700 KRW, the stock appears Overvalued by 16% .